Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Thonon-les-bains – page 2

22 clinical trials in Thonon-les-bains, France. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Thonon-les-bains at a glance
22
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

22 trials in Thonon-les-bains

Open in trial search
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Capecitabine
  • Sponsor:Fondation Franc.Cancerologie Digestive
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Everolimus
  • Sponsor:Unicancer
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Avelumab
  • Sponsor:Groupe Oncologie Radiotherapie Tete Cou
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Unicancer
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Letrozole
  • Sponsor:Solti Group
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Unicancer
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Fondation Franc.Cancerologie Digestive
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Alpelisib
  • Sponsor:Unicancer
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Fluorouracil
  • Sponsor:Unicancer
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Clinipace Global Limited

Other cities in France

The busiest research cities in the country

All 379 cities in France

Clinical research in Thonon-les-bains

What the registry says about research in the country

01 Breast Cancer Research

Innovative clinical trials focusing on hormone receptor-positive (HR+) and triple-negative breast cancer treatments, investigating targeted therapies and personalized approaches.

  • Pembrolizumab effectiveness in early TNBC
  • Hormone therapy combinations with novel agents
  • Circulating tumor DNA detection methods

Studies evaluating treatment responses in different patient populations, with particular attention to genomic markers and personalized medicine approaches.

02 Prostate Cancer Studies

Research investigating treatments for castration-resistant prostate cancer and high-risk prostate adenocarcinoma, exploring both conventional and innovative therapeutic approaches.

  • Combination therapy with acetylsalicylic acid and atorvastatin
  • Adjuvant hormonal treatments
  • Post-surgery therapy optimization

Focus on improving survival rates and reducing recurrence in high-risk patients through targeted interventions.

03 Advanced Cancer Therapies

Comprehensive research programs examining novel treatment combinations for various cancer types, including head and neck, lung, and anal cancers.

  • Immunotherapy combinations in head and neck cancer
  • Non-small cell lung cancer treatments
  • Colon cancer adjuvant therapies

Studies aimed at improving treatment outcomes through innovative drug combinations and targeted approaches.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.